[Clinical evaluation of amitriptyline in the treatment of psychogenic disorders].
Clinical evaluation of amytyptiline in the treatment of psychogenic disorders was performed, using one or more 25 mg doses daily per os. Of the patients, 19 were male and 11 female; ages were between 18 and 55. Treatment for each lasted 12 weeks, and clinical improvement was observed from the second to the fifth week, with mild side effects that did not require treatment. Psychotherapy was instituted during treatment. ;inal results were: 23 good improvement, 4 some improvement and 3, no change.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy*; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets
D013607:Tablets; D000639:Amitriptyline
Valoración clinica de la amitriptilina en el tratamiento de los trastornos psicógenos